ANACOR PHARMACEUTICALS INC's ticker is ANAC and the CUSIP is 032420101. A total of 142 filers reported holding ANACOR PHARMACEUTICALS INC in Q4 2014. The put-call ratio across all filers is 2.00 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $683,000 | -38.3% | 12,775 | +30.4% | 0.04% | -40.0% |
| Q4 2015 | $1,107,000 | -37.8% | 9,795 | -35.2% | 0.06% | -27.8% |
| Q3 2015 | $1,780,000 | +905.6% | 15,124 | +562.8% | 0.09% | +900.0% |
| Q2 2015 | $177,000 | -71.9% | 2,282 | -88.3% | 0.01% | -73.5% |
| Q4 2014 | $629,000 | +308.4% | 19,515 | +210.2% | 0.03% | +277.8% |
| Q3 2014 | $154,000 | – | 6,292 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 54,476 | $5,407,000 | 0.30% |
| CIM INVESTMENT MANAGEMENT INC | 3,377 | $335,000 | 0.14% |
| MASSMUTUAL TRUST CO FSB/ADV | 0 | $0 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 55,700 | $0 | 0.00% |
| EQUITEC SPECIALISTS, LLC | 69,000 | $0 | 0.00% |